These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26673820)

  • 21. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma.
    Sugimura K; Miyata H; Tanaka K; Hamano R; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Clin Cancer Res; 2012 Sep; 18(18):5144-53. PubMed ID: 22847808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of tumor regression grade for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery.
    Hatogai K; Fujii S; Kojima T; Daiko H; Kadota T; Fujita T; Yoshino T; Doi T; Takiguchi Y; Ohtsu A
    J Surg Oncol; 2016 Mar; 113(4):390-6. PubMed ID: 27100024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
    Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
    J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma.
    Langer R; Specht K; Becker K; Ewald P; Bekesch M; Sarbia M; Busch R; Feith M; Stein HJ; Siewert JR; Höfler H
    Clin Cancer Res; 2005 Oct; 11(20):7462-9. PubMed ID: 16243820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
    Hu YC; Lam KY; Law S; Wong J; Srivastava G
    Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus.
    Yamasaki M; Miyata H; Fujiwara Y; Takiguchi S; Nakajima K; Nishida T; Yasuda T; Matsuyama J; Mori M; Doki Y
    Ann Surg Oncol; 2010 Feb; 17(2):634-42. PubMed ID: 19941080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.
    Makino T; Yamasaki M; Miyata H; Yoshioka S; Takiguchi S; Fujiwara Y; Nakajima K; Nishida T; Mori M; Doki Y
    Ann Surg Oncol; 2010 Mar; 17(3):804-11. PubMed ID: 19885698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers.
    Kharma B; Baba T; Mandai M; Matsumura N; Murphy SK; Kang HS; Yamanoi K; Hamanishi J; Yamaguchi K; Yoshioka Y; Konishi I
    Int J Cancer; 2013 Nov; 133(9):2234-44. PubMed ID: 23595697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines.
    Hummel R; Sie C; Watson DI; Wang T; Ansar A; Michael MZ; Van der Hoek M; Haier J; Hussey DJ
    World J Gastroenterol; 2014 Oct; 20(40):14904-12. PubMed ID: 25356050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1 mRNA expression as a predictive and prognostic marker in advanced esophageal squamous cell carcinoma treated with cisplatin- or docetaxel-based chemotherapy/chemoradiotherapy.
    Gao Y; Zhu J; Zhang X; Wu Q; Jiang S; Liu Y; Hu Z; Liu B; Chen X
    PLoS One; 2013; 8(1):e52589. PubMed ID: 23326344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant Chemotherapy Induces IL34 Signaling and Promotes Chemoresistance via Tumor-Associated Macrophage Polarization in Esophageal Squamous Cell Carcinoma.
    Nakajima S; Mimura K; Saito K; Thar Min AK; Endo E; Yamada L; Kase K; Yamauchi N; Matsumoto T; Nakano H; Kanke Y; Okayama H; Saito M; Neupane P; Saze Z; Watanabe Y; Hanayama H; Hayase S; Kaneta A; Momma T; Ohki S; Ohira H; Kono K
    Mol Cancer Res; 2021 Jun; 19(6):1085-1095. PubMed ID: 33674443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prediction of response to neoadjuvant chemotherapy in Barrett's carcinoma by quantitative gene expression analysis].
    Langer R; Specht K; Becker K; Ewald P; Sarbia M; Busch R; Feith M; Stein HJ; Siewert JR; Höfler H
    Verh Dtsch Ges Pathol; 2004; 88():207-13. PubMed ID: 16892554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy.
    Tanaka K; Mohri Y; Ohi M; Yokoe T; Koike Y; Morimoto Y; Miki C; Tonouchi H; Kusunoki M
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):639-46. PubMed ID: 18691855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC.
    Hu YC; Lam KY; Law S; Wong J; Srivastava G
    Clin Cancer Res; 2001 Aug; 7(8):2213-21. PubMed ID: 11489794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression profiling of the response of esophageal carcinoma cells to cisplatin.
    Takashima N; Ishiguro H; Kuwabara Y; Kimura M; Mitui A; Mori Y; Mori R; Tomoda K; Hamaguchi M; Ogawa R; Katada T; Harada K; Fujii Y
    Dis Esophagus; 2008; 21(3):230-5. PubMed ID: 18430104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression analysis of pretreatment biopsies predicts the pathological response of esophageal squamous cell carcinomas to neo-chemoradiotherapy.
    Wen J; Yang H; Liu MZ; Luo KJ; Liu H; Hu Y; Zhang X; Lai RC; Lin T; Wang HY; Fu JH
    Ann Oncol; 2014 Sep; 25(9):1769-1774. PubMed ID: 24907633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.
    Xi H; Baldus SE; Warnecke-Eberz U; Brabender J; Neiss S; Metzger R; Ling FC; Dienes HP; Bollschweiler E; Moenig S; Mueller RP; Hoelscher AH; Schneider PM
    Clin Cancer Res; 2005 Dec; 11(23):8341-7. PubMed ID: 16322294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High serum levels of vascular endothelial growth factor-A and transforming growth factor-β1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapy.
    Cheng JC; Graber MS; Hsu FM; Tsai CL; Castaneda L; Lee JM; Chang DT; Koong AC
    Ann Surg Oncol; 2014 Jul; 21(7):2361-8. PubMed ID: 24623035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
    Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
    Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is There a Correlation Between Clinical Complete Response and Pathological Complete Response After Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Cancer?
    Liu SL; Xi M; Yang H; Yang YD; Wu YJ; Zhao L; Zhang P; Luo LL; Liu MZ
    Ann Surg Oncol; 2016 Jan; 23(1):273-81. PubMed ID: 26215200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.